Triaminic & Theraflu Syrups (Novartis) – Closure Failure (2013)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Consumer Product Safety Commission (CPSC)
Product
Triaminic® Syrups and Theraflu Warming Relief® Syrups
Brand
Novartis Consumer Health Inc., of Parsippany, NJ
Lot Codes / Batch Numbers
Not specified in CPSC notice. Check official source for details.
Product Images
Source: U.S. Consumer Product Safety Commission
Novartis Consumer Health Inc., of Parsippany, NJ is recalling Triaminic® Syrups and Theraflu Warming Relief® Syrups. The hazard is: These child-resistant caps can fail to function properly and enable the cap to be removed by a child. Based on CPSC recall notice.
Summary derived from CPSC notice
The following details were not provided by CPSC: UPC codes.
Reason for Recall
As stated by CPSC
This recall involves Triaminic® Syrups and Theraflu Warming Relief® Syrups for coughs, colds and fevers. There are 24 types of these two products included in the recall. A complete list of products, lot numbers and National Drug Codes (NDC) can be found at www.novartisOTC.com. Lot numbers are located on the bottom panel of the box and on the left side of the label on the bottle. The NDC number is located on the upper right corner of the front panel of the Triaminic Syrups box and the upper left corner of the Theraflu Warming Relief Syrups bottle.
Reported concern (CPSC)
These child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place, posing a risk of unintentional ingestion and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Recommended Action
Per CPSC guidance
Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.
Verify this information on the official source
For complete details and official instructions, check the U.S. Consumer Product Safety Commission (CPSC) directly.
View official CPSC recall noticePage updated: Jan 6, 2026